Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo therapy aims to slow aggressive gut tumors

NCT ID NCT07185672

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times

Summary

This study tests whether adding chemotherapy to standard radiation therapy (PRRT) helps people with advanced neuroendocrine tumors of the stomach, intestines, or pancreas that appear active on a special PET scan. About 162 adults with tumors that have spread or cannot be removed will receive either PRRT alone or PRRT plus chemotherapy pills. The goal is to see if the combination delays tumor growth and improves survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE NEOPLASIA'S (NENS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)

    RECRUITING

    Navi Mumbai, Maharashtra, 410210, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tata Memorial Hospital, Mumbai, India

    RECRUITING

    Mumbai, Maharashtra, 400012, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.